T1	Participants 70 93	moderate to severe COPD
T2	Participants 369 418	subjects with symptomatic moderate to severe COPD
T3	Participants 510 716	Subjects 40 years or older with cigarette smoking history ≥10 pack-years and with the diagnosis of COPD and post-bronchodilator FEV(1) ≥40 to ≤ 80% of predicted normal and FEV(1)/FVC of ≤0.70 were enrolled.
T4	Participants 1599 1617	subjects with COPD
